Funding for this research was provided by:
American Society of Hematology Scholars
Ludwig Cancer Research
Chan Zuckerberg Investigator
Received: 30 April 2019
Accepted: 29 October 2019
First Online: 2 December 2019
: R.M. is a founder of, is an equity holder in, and serves on the board of directors of Forty Seven. H.Y.C. has affiliations with Accent Therapeutics (founder and scientific advisory board (SAB) member), 10x Genomics (SAB member), Boundless Bio (cofounder, SAB), Arsenal Biosciences (SAB) and Spring Discovery (SAB member). W.J.G. has affiliations with 10x Genomics (consultant), Guardant Health (consultant) and Protillion Biosciences (co-founder and consultant).